Top pharmaceutical R&D projects based on net present value May 2019
Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
This statistic depicts the most valuable research and development projects in the pharmaceutical industry worldwide as of May 2019, based on net present value in million U.S. dollars. AbbVie's Upadacitinib project claimed a net present value of 10.25 billion U.S. dollars as of May 2019.
Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
Loading statistic...
| Product (Company) | Net present value in million U.S. dollars |
|---|---|
| VX-659/VX-445+Tezacaftor+Ivacaftor (Vertex) | 19,984 |
| Upadacitinib (AbbVie) | 10,246 |
| DS-8201 (Daiichi Sankyo) | 9,111 |
| Liso-celn (Celgene) | 8,986 |
| Zolgensma (Novartis) | 8,011 |
Source
More information
Statistics on "Clinical trials"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top new orphan molecular entities by U.S. sales in 2019
- Count of first-time medtech approvals granted by FDA 2006-2017
- Top drugs based on projected 2019 year-on-year sales increase
- Projection of top 10 global pharmaceutical products by revenue 2019
- Top U.S. proton pump inhibitors' revenue market share 2013
- Italy: number of biotech projects along the drug pipeline 2016-2017, by area
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Share of global pharmaceutical gross value added by product type 2012
- Top U.S. proton pump inhibitors based on revenue 2013
- Top U.S. proton pump inhibitors market share based on prescriptions 2013
- Top U.S. proton pump inhibitors based on prescriptions 2013
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Global pharmaceutical gross value added by product type 2012
- Top salaries U.S. pharmaceutical sales vs other medical sales 2018, by product
- Small molecules facing loss of developed market exclusivity 2011-2020
- Manufacture of optical and photographic equipment revenue in Denmark 2010-2022
- Products for pharmaceutical uses: import value in the United Kingdom (UK) 2010-2013
- Forecast: revenue pharmaceutical preparation manufacture Ireland 2009-2020
- Industry revenue of »manufacture of basic pharmaceutical products« in Cyprus 2011-2023
- Poland: medicament mixtures in dosage export value 2012-2018
Statistics on "Clinical trials"
Related topics
About Statista
